Anti-LSD2 / AOF1 antibody [EPR18508]
- RabMAb
- Recombinant
- KO Validated
- 20ul selling size
- 각 태그의 뜻
Be the first to review this product! 리뷰 제출
|
(5 제품이 사용된 논문 )
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-LSD2 / AOF1 antibody [EPR18508] (AB193080)
Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized A431 (Human epidermoid carcinoma) cells labeling LSD2 / AOF1 with ab193080 at 1/500 dilution, followed by Goat anti-rabbit IgG (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green).
Confocal image showing nuclear staining on A431 cell line.
The nuclear counterstain is DAPI (blue).
Tubulin is detected with ab7291 (anti-Tubulin mouse mAb) at 1/1000 dilution and ab150120 (AlexaFluor®594 Goat anti-Mouse secondary) at 1/1000 dilution (red).
The negative controls are as follows : -
-ve control 1 : ab193080 at 1/500 dilution followed by ab150120 (AlexaFluor®594 Goat anti-Mouse secondary) at 1/1000 dilution.
-ve control 2 : ab7291 (anti-Tubulin mouse mAb) at 1/1000 dilution followed by ab150077 (Alexa Fluor®488 Goat Anti-Rabbit IgG H&L) at 1/1000 dilution.
- Flow Cyt (Intra)
Lab
Flow Cytometry (Intracellular) - Anti-LSD2 / AOF1 antibody [EPR18508] (AB193080)
Intracellular Flow Cytometry analysis of HeLa (human cervix adenocarcinoma) cells labelling LSD2 / AOF1 antibody (red) with purified ab193080 at a dilution of 1/70. Goat anti rabbit IgG (Alexa Fluor® 488) was used as the secondary antibody at 1/2000. Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. Isotype control antibody was Rabbit monoclonal IgG (black). The blue line shows cells without incubation with primary antibody and secondary antibody.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-LSD2 / AOF1 antibody [EPR18508] (AB193080)
Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized HeLa (Human epithelial cells from cervix adenocarcinoma) cells labeling LSD2 / AOF1 with ab193080 at 1/500 dilution, followed by Goat anti-rabbit IgG (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green).
Confocal image showing nuclear staining on HeLa cell line.
The nuclear counterstain is DAPI (blue).
Tubulin is detected with ab7291 (anti-Tubulin mouse mAb) at 1/1000 dilution and ab150120 (AlexaFluor®594 Goat anti-Mouse secondary) at 1/1000 dilution (red).
The negative controls are as follows :
-ve control 1 : ab193080 at 1/500 dilution followed by ab150120 (AlexaFluor®594 Goat anti-Mouse secondary) at 1/1000 dilution.
-ve control 2 : ab7291 (anti-Tubulin mouse mAb) at 1/1000 dilution followed by ab150077 (Alexa Fluor®488 Goat Anti-Rabbit IgG H&L) at 1/1000 dilution.
- IP
Supplier Data
Immunoprecipitation - Anti-LSD2 / AOF1 antibody [EPR18508] (AB193080)
LSD2 / AOF1 was immunoprecipitated from 1mg of K562 (Human chronic myelogenous leukemia cells from bone marrow) whole cell lysate with ab193080 at 1/80 dilution.
Lane 1 : K562 whole cell lysate 10ug (Input).
Lane 2 : ab193080 IP in K562 whole cell lysate.
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab193080 in K562 whole cell lysate.
Western blot was performed from the immunoprecipitate using ab193080 at 1/1000 dilution. Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG, was used as secondary antibody at 1/1500.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 8 seconds.
All lanes:
Immunoprecipitation - Anti-LSD2 / AOF1 antibody [EPR18508] (ab193080)
Predicted band size: 92 kDa
false
- WB
Lab
Western blot - Anti-LSD2 / AOF1 antibody [EPR18508] (AB193080)
Lane 1 : Wild-type HAP1 cell lysate (20 μg)
Lane 2 : LSD2 / AOF1 knockout HAP1 cell lysate (20 μg)
Lane 3 : PC12 cell lysate (20 μg)
Lane 4 : Raw264.7 cell lysate (20 μg)
Lanes 1 - 4 : Merged signal (red and green). Green - ab193080 observed at 95 kDa. Red - loading control, ab8245, observed at 37 kDa.
ab193080 was shown to specifically react with LSD2 / AOF1 when LSD2 / AOF1 knockout samples were used. Wild-type and LSD2 / AOF1 knockout samples were subjected to SDS-PAGE. ab193080 and ab8245 (loading control to GAPDH) were diluted at 1/2000 and 1/10 000 respectively and incubated overnight at 4°C. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1/10 000 dilution for 1 h at room temperature before imaging.
All lanes:
Western blot - Anti-LSD2 / AOF1 antibody [EPR18508] (ab193080)
Predicted band size: 92 kDa
false
- WB
Supplier Data
Western blot - Anti-LSD2 / AOF1 antibody [EPR18508] (AB193080)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-LSD2 / AOF1 antibody [EPR18508] (ab193080) at 1/2000 dilution
Lane 1:
Human fetal brain lysate at 10 µg
Lane 2:
Human fetal heart lysate at 10 µg
Secondary
All lanes:
Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/10000 dilution
Predicted band size: 92 kDa
Observed band size: 92 kDa
false
Exposure time: 3min
- WB
Lab
Western blot - Anti-LSD2 / AOF1 antibody [EPR18508] (AB193080)
Lanes 1-4 : Merged signal (red and green). Green - ab193080 observed at 95 kDa. Red - loading control ab8245 observed at 36 kDa.
ab193080 Anti-LSD2 / AOF1 antibody [EPR18508] was shown to specifically react with LSD2 / AOF1 in wild-type HeLa cells. Loss of signal was observed when knockout cell line ab265969 (knockout cell lysate ab258016) was used. Wild-type and LSD2 / AOF1 knockout samples were subjected to SDS-PAGE. ab193080 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated at room temperature for 2. 5 hours at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-LSD2 / AOF1 antibody [EPR18508] (ab193080) at 1/1000 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
Western blot - Human KDM1B (LSD2 / AOF1) knockout HeLa cell lysate (<a href='/ko/products/cell-lysates/human-kdm1b-lsd2-aof1-knockout-hela-cell-lysate-ab258016'>ab258016</a>) at 20 µg
Lane 3:
HAP1 cell lysate at 20 µg
Lane 4:
HCT116 cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (<a href='/ko/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-800cw-preadsorbed-ab216773'>ab216773</a>) at 1/10000 dilution
Predicted band size: 92 kDa
Observed band size: 95 kDa
false
- WB
Supplier Data
Western blot - Anti-LSD2 / AOF1 antibody [EPR18508] (AB193080)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-LSD2 / AOF1 antibody [EPR18508] (ab193080) at 1/2000 dilution
Lane 1:
NIH/3T3 (Mouse embyro fibroblast cells) cell lysate at 20 µg
Lane 2:
Mouse thymus lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/ko/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/50000 dilution
Predicted band size: 92 kDa
Observed band size: 92 kDa
false
Exposure time: 3min
- WB
Supplier Data
Western blot - Anti-LSD2 / AOF1 antibody [EPR18508] (AB193080)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-LSD2 / AOF1 antibody [EPR18508] (ab193080) at 1/2000 dilution
Lane 1:
C6 (Rat glial tumor cells) cell lysate at 10 µg
Lane 2:
RAW 264.7 (Mouse macrophage cells transformed with Abelson murine leukemia virus) cell lysate at 10 µg
Lane 3:
PC-12 (Rat adrenal gland pheochromocytoma) cell lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/ko/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/1000 dilution
Predicted band size: 92 kDa
Observed band size: 92 kDa
false
Exposure time: 3min
관련 conjugated 항체와 다양한 조성의 항체 (3)
-
Anti-LSD2 / AOF1 antibody [EPR18508] - BSA and Azide free
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-LSD2 / AOF1 antibody [EPR18508]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-LSD2 / AOF1 antibody [EPR18508]
Reactivity 정보
제품 세부 정보
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
특성 및 보관 정보
제형
Purification 테크닉
보관 버퍼
배송 시 보관 조건
적절한 단기 보관 기간
적절한 단기 보관 조건
적절한 장기 보관 조건
분주 정보
보관 정보
추가 정보
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
LSD2 impacts gene expression by altering the epigenetic state of chromatin. It is not part of a well-defined large multiprotein complex allowing LSD2 to directly interact with histones. Through its demethylase activity it modulates the transcriptional regulation impacting cellular differentiation and proliferation. This makes it an important factor in maintaining cellular homeostasis.
Pathways
LSD2 is involved in histone modification processes particularly through the demethylation of H3K4me1 and H3K4me2 marks. These changes are important in the regulation of gene expression patterns. LSD2 often interacts with the REST corepressor complex affecting the expression of genes involved in neural development and function. It plays a role in pathways related to cellular stress responses and metabolic regulation highlighting its importance in cellular adaptation mechanisms.
제품 프로토콜
- Visit the General protocols
- Visit the Troubleshooting
타겟 정보
대체 명칭 보기
제품이 사용된 논문 (5)
Recent publications for all applications. Explore the 전체 목록and refine your search
Cytotechnology 74:579-590 PubMed36238269
2022
Applications
Unspecified application
Species
Unspecified reactive species
Aging 12:14990-15001 PubMed32726297
2020
Applications
Unspecified application
Species
Unspecified reactive species
Oncotarget 10:3865-3878 PubMed31231465
2019
Applications
Unspecified application
Species
Unspecified reactive species
Oncotarget 9:36413-36429 PubMed30559927
2018
Applications
Unspecified application
Species
Unspecified reactive species
Nature cell biology 20:1181-1192 PubMed30202049
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com